Clairmed Pharmaceuticals Private Limited
About Clairmed Pharmaceuticals Private Limited
Data last updated:
Clairmed Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 09 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2019PTC113427. Its GSTIN is 09AAICC0100G1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.25 Lakh. It is led by directors including Savendra Singh and Praveen Kumar Khanna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 314/68 Mirza Mandi Chowk, Lucknow, Uttar Pradesh, India – 226003.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Clairmed Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address314/68 Mirza Mandi Chowk, Lucknow, Uttar Pradesh, India – 226003
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
To see the full contact details of Clairmed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Clairmed Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Clairmed Pharmaceuticals Private Limited, buy the company report.
Financials of Clairmed Pharmaceuticals Private Limited
FY 2025 filings availableClairmed Pharmaceuticals Private Limited reported revenue of ₹1,049 (down 100% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 84% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Clairmed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Clairmed Pharmaceuticals Private Limited
Clairmed Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Savendra Singh Also directs: Vama Regalia LLP, Clairvoyance Biotech (India) Limited | Director | 09 Feb 2019 | 7 Years 8 Months | Current |
| Praveen Kumar Khanna | Director | 09 Feb 2019 | 7 Years 8 Months | Current |
| Chetan Saxena | Director | 23 Dec 2024 | 1 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Clairmed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clairmed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Clairmed Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICC0100G1Z9 | Uttar Pradesh | Active | 16 Sep 2019 |
To see the full GST registrations and return filing status of Clairmed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Clairmed Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Chetan Saxena was appointed as Director on 23 Dec 2024.
Frequently asked questions
Clairmed Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 09 February 2019 (7+ years old) and is registered under CIN U24299UP2019PTC113427.
Clairmed Pharmaceuticals has 3 current directors:
- Savendra Singh - Director
- Praveen Kumar Khanna - Director
- Chetan Saxena - Director
The latest financial statements of Clairmed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Clairmed Pharmaceuticals is 09AAICC0100G1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Clairmed Pharmaceuticals is U24299UP2019PTC113427. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clairmed Pharmaceuticals was incorporated on 09 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Chetan Saxena was appointed as Director on 23 Dec 2024. Praveen Kumar Khanna was appointed as Director on 09 Feb 2019. Savendra Singh was appointed as Director on 09 Feb 2019.
The registered office of Clairmed Pharmaceuticals is at 31468 Mirza Mandi Chowk, Lucknow, Uttar Pradesh, India – 226003.
Clairmed Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.
The compliance status of Clairmed Pharmaceuticals is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.